← Leaderboards
Sally E Wenzel
University Of Colorado Denver
$36,525,494
Attributed
$62,146,316
Total exposure
26
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$77,310,817 · 27
By mechanism
R01$24,947,112 · 8
P01$20,149,987 · 6
U01$17,276,351 · 1
U10$8,597,918 · 2
RC2$3,489,267 · 1
UG1$2,374,766 · 1
Top collaborators
- Deborah A. Meyers10 shared
- Anuradha Ray9 shared
- Mario Castro8 shared
- Suzy Comhair8 shared
- Loren C Denlinger8 shared
- Eric A Hoffman8 shared
- Elliot Israel8 shared
- Purveshkumar Khatri8 shared
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaCellsPathway InteractionsResponsePhenotypeInflammationInflammatoryEpithelial CellsProgramsBaseSputumMolecular PhenotypeSeveritiesIn VitroMolecularAsthmaticGeneticIn VivoEpithelialTissuesPatternEpitheliumProteinsAdrenal Cortex Hormones
Grant awards (117)
Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma$1,868,594
P01 · FY2025 · AI
Project 2$501,567
P01 · FY2025 · AI · contact PI
Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma$1,868,594
P01 · FY2024 · AI
Project 2$505,176
P01 · FY2024 · AI · contact PI
2024 Pittsburgh International Lung Conference: From Smog to Social Equity: How the Exposome Shapes Our Respiratory Health$35,000
R13 · FY2024 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$3,233,979
U01 · FY2023 · HL
Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma$1,868,594
P01 · FY2023 · AI
Mucin sialylation drives epithelial cell senescence and severe asthma$695,513
R01 · FY2023 · HL · contact PI
Project 2$536,661
P01 · FY2023 · AI · contact PI
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control Â$535,092
R01 · FY2023 · AI · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$216,239
U01 · FY2023 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$3,322,614
U01 · FY2022 · HL
Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma$1,878,574
P01 · FY2022 · AI
Mucin sialylation drives epithelial cell senescence and severe asthma$695,967
R01 · FY2022 · HL · contact PI
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control Â$540,033
R01 · FY2022 · AI · contact PI
Project 2$504,146
P01 · FY2022 · AI · contact PI
Rapid saliva antigen test for SARS-CoV-2 detection$434,002
U01 · FY2022 · HL
Type-2 or Not Type-2: That is the (Therapeutic) Question$364,876
UG1 · FY2022 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$235,989
U01 · FY2022 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$3,058,207
U01 · FY2021 · HL
Mucin sialylation drives epithelial cell senescence and severe asthma$689,996
R01 · FY2021 · HL · contact PI
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control Â$657,667
R01 · FY2021 · AI · contact PI
Type-2 or Not Type-2: That is the (Therapeutic) Question$408,516
UG1 · FY2021 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,355,708
U01 · FY2020 · HL
Mucin sialylation drives epithelial cell senescence and severe asthma$746,830
R01 · FY2020 · HL · contact PI
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control Â$534,504
R01 · FY2020 · AI · contact PI
Type-2 or Not Type-2: That is the (Therapeutic) Question$413,983
UG1 · FY2020 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,419,613
U01 · FY2019 · HL
Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma$1,538,631
P01 · FY2019 · AI
Type-2 or Not Type-2: That is the (Therapeutic) Question$421,808
UG1 · FY2019 · HL · contact PI
Project 2 Impact of Innate and Adaptive Immunity At the Airway Epithelium in Severe Asthma$390,444
P01 · FY2019 · AI · contact PI
Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma$1,533,612
P01 · FY2018 · AI
Toward PanOmic and Personalized Association Study of Complex Diseases - A New Statistical and Computational Paradigm for Personalized Medicine$529,089
R01 · FY2018 · GM
Type-2 or Not Type-2: That is the (Therapeutic) Question$429,633
UG1 · FY2018 · HL · contact PI
Project 2 Impact of Innate and Adaptive Immunity At the Airway Epithelium in Severe Asthma$389,619
P01 · FY2018 · AI · contact PI
Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma$1,534,851
P01 · FY2017 · AI
Toward PanOmic and Personalized Association Study of Complex Diseases - A New Statistical and Computational Paradigm for Personalized Medicine$529,970
R01 · FY2017 · GM
Project 2 Impact of Innate and Adaptive Immunity At the Airway Epithelium in Severe Asthma$390,442
P01 · FY2017 · AI · contact PI
Type-2 or Not Type-2: That is the (Therapeutic) Question$335,950
UG1 · FY2017 · HL · contact PI
Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma$1,534,850
P01 · FY2016 · AI
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma$669,568
U10 · FY2016 · HL · contact PI
Toward PanOmic and Personalized Association Study of Complex Diseases - A New Statistical and Computational Paradigm for Personalized Medicine$530,826
R01 · FY2016 · GM
Project 2 Impact of Innate and Adaptive Immunity At the Airway Epithelium in Severe Asthma$461,919
P01 · FY2016 · AI · contact PI
Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma$1,538,201
P01 · FY2015 · AI
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma$662,578
U10 · FY2015 · HL · contact PI
Toward PanOmic and Personalized Association Study of Complex Diseases - A New Statistical and Computational Paradigm for Personalized Medicine$571,578
R01 · FY2015 · GM
Project 2 Impact of Innate and Adaptive Immunity At the Airway Epithelium in Severe Asthma$382,148
P01 · FY2015 · AI · contact PI
AsthmaNet: Phenotypic Influences on Asthma Treatments$253,408
U10 · FY2015 · HL · contact PI
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma$675,469
U10 · FY2014 · HL · contact PI
AsthmaNet: Phenotypic Influences on Asthma Treatments$494,957
U10 · FY2014 · HL · contact PI
Amplification of IL-4Ralpha signaling pathways in human airways through 15 LO1$363,267
R01 · FY2014 · AI · contact PI
AsthmaNet: Phenotypic Influences on Asthma Treatments$849,636
U10 · FY2013 · HL · contact PI
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma$645,574
U10 · FY2013 · HL · contact PI
Amplification of IL-4Ralpha signaling pathways in human airways through 15 LO1$341,456
R01 · FY2013 · AI · contact PI
AsthmaNet: Phenotypic Influences on Asthma Treatments$852,487
U10 · FY2012 · HL · contact PI
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma$687,458
U10 · FY2012 · HL · contact PI
Amplification of IL-4Ralpha signaling pathways in human airways through 15 LO1$363,234
R01 · FY2012 · AI · contact PI
AsthmaNet: Phenotypic Influences on Asthma Treatments$857,131
U10 · FY2011 · HL · contact PI
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma$582,010
U10 · FY2011 · HL · contact PI
Amplification of IL-4Ralpha signaling pathways in human airways through 15 LO1$366,428
R01 · FY2011 · AI · contact PI
Linking Genetics, Genomics and Phenomics to Better Understand Asthma Severity$1,787,959
RC2 · FY2010 · HL
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma$904,560
R01 · FY2010 · HL · contact PI
AsthmaNet: Phenotypic Influences on Asthma Treatments$838,101
U10 · FY2010 · HL · contact PI
Genome-Transcription-Phenome-Wide Association: a new paradigm for association stu$515,713
R01 · FY2010 · GM
Amplification of IL-4Ralpha signaling pathways in human airways through 15 LO1$389,377
R01 · FY2010 · AI · contact PI
Th2 effects on eicosanoid pathways: implications for altered innate responses in$353,188
R01 · FY2010 · AI · contact PI
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma$30,120
R01 · FY2010 · HL · contact PI
Linking Genetics, Genomics and Phenomics to Better Understand Asthma Severity$1,701,308
RC2 · FY2009 · HL
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma$899,273
R01 · FY2009 · HL · contact PI
Genome-Transcription-Phenome-Wide Association: a new paradigm for association stu$544,383
R01 · FY2009 · GM
AsthmaNet: Phenotypic Influences on Asthma Treatments$529,541
U10 · FY2009 · HL · contact PI
Th2 effects on eicosanoid pathways: implications for altered innate responses$356,664
R01 · FY2009 · AI · contact PI
TGF-beta2 and IL-4Ralpha Pathway Interactions in Asthma$310,793
R01 · FY2009 · AI · contact PI
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma$49,828
R01 · FY2009 · HL · contact PI
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma$858,566
R01 · FY2008 · HL · contact PI
Th2 effects on eicosanoid pathways: implications for altered innate responses$356,575
R01 · FY2008 · AI · contact PI
TGF-beta2 and IL-4Ralpha Pathway Interactions in Asthma$310,793
R01 · FY2008 · AI · contact PI
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma$855,867
R01 · FY2007 · HL · contact PI
Th2 effects on eicosanoid pathways: implications for altered innate responses$362,683
R01 · FY2007 · AI · contact PI
TGF-beta2 and IL-4Ralpha Pathway Interactions in Asthma$316,811
R01 · FY2007 · AI · contact PI
INTERLEUKIN 13$2,693
M01 · FY2007 · RR · contact PI
TGF-BETA2 AND IL-4RA PATHWAY INTERACTIONS IN ASTHMA$1,346
M01 · FY2007 · RR · contact PI
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma$904,372
R01 · FY2006 · HL · contact PI
Th2 effects on eicosanoid pathways: implications for altered innate responses in$288,167
R01 · FY2006 · AI · contact PI
TGF-beta2 and IL-4Ralpha Pathway Interactions in Asthma$225,642
R01 · FY2006 · AI · contact PI
TGF-beta2 and IL-4Ralpha Pathway Interactions in Asthma$105,500
R01 · FY2006 · AI · contact PI
Th2 effects on eicosanoid pathways: implications for altered innate responses in$49,059
R01 · FY2006 · AI · contact PI
INTERLEUKIN 13$8,355
M01 · FY2006 · RR · contact PI
TGF-BETA2 AND IL-4RA PATHWAY INTERACTIONS IN ASTHMA$2,166
M01 · FY2006 · RR · contact PI
IL-13, MYOFIBROBLASTS &ELASTIC RECOIL IN SEVERE ASTHMA$1,030,399
R01 · FY2005 · HL
TGF-beta2 and IL-4Ralpha Pathway Interactions in Asthma$341,100
R01 · FY2005 · AI
CORE--CLINICAL$264,498
P01 · FY2005 · HL
INTERLEUKIN 13$6,005
M01 · FY2005 · RR
TRANSFORMING GROWTH FACTOR$587
M01 · FY2005 · RR
IL-13, MYOFIBROBLASTS &ELASTIC RECOIL IN SEVERE ASTHMA$1,016,838
R01 · FY2004 · HL
TGF-BETA AND 15 HETE IN POORLY STEROID RESPONSIVE ASTHMA$269,150
R01 · FY2004 · AI
Transforming Growth Factor$2,925
M01 · FY2004 · RR
Interleukin 13 (SARP)$2,633
M01 · FY2004 · RR
IL-13, MYOFIBROBLASTS &ELASTIC RECOIL IN SEVERE ASTHMA$1,000,684
R01 · FY2003 · HL
TGF-BETA AND 15 HETE IN POORLY STEROID RESPONSIVE ASTHMA$269,150
R01 · FY2003 · AI
Severe Asthma Research Project$568,399
R01 · FY2002 · HL
IL-13, MYOFIBROBLASTS &ELASTIC RECOIL IN SEVERE ASTHMA$520,033
R01 · FY2002 · HL
TGF-BETA AND MATRIX METALLOPROTEINASES IN AIRWAY REPAIR$307,600
R01 · FY2002 · HL
TGF-BETA AND 15 HETE IN POORLY STEROID RESPONSIVE ASTHMA$269,150
R01 · FY2002 · AI
LEUKOTRIENE B4 IN GLUCOCORTICOID INSENSITIVE ASTHMA$190,747
M01 · FY2002 · RR
CORE--CLINICAL$186,552
P01 · FY2002 · HL
IL-13, MYOFIBROBLASTS &ELASTIC RECOIL IN SEVERE ASTHMA$521,725
R01 · FY2001 · HL
TGF-BETA AND MATRIX METALLOPROTEINASES IN AIRWAY REPAIR$307,600
R01 · FY2001 · HL
TGF-BETA AND 15 HETE IN POORLY STEROID RESPONSIVE ASTHMA$269,150
R01 · FY2001 · AI
LEUKOTRIENE B4 IN GLUCOCORTICOID INSENSITIVE ASTHMA$190,747
M01 · FY2001 · RR
CORE--CLINICAL$186,552
P01 · FY2001 · HL
LEUKOTRIENE B4 IN GLUCOCORTICOID INSENSITIVE ASTHMA$0
M01 · FY2001 · RR
TGF-BETA AND MATRIX METALLOPROTEINASES IN AIRWAY REPAIR$307,600
R01 · FY2000 · HL
CORE--CLINICAL$285,762
P01 · FY2000 · HL
TGF-BETA AND 15 HETE IN POORLY STEROID RESPONSIVE ASTHMA$269,150
R01 · FY2000 · AI
LEUKOTRIENE B4 IN GLUCOCORTICOID INSENSITIVE ASTHMA$32,212
M01 · FY2000 · RR
LEUKOTRIENE B4 IN GLUCOCORTICOID INSENSITIVE ASTHMA$0
M01 · FY2000 · RR